Abstract
We previously reported that the hypermethylation of the p15INK4B gene promoter was frequently observed in myelodysplastic syndromes (MDS), and that it may be associated with disease progression. An unanswered question is whether p15INK4B gene methylation is restricted to undifferentiated blastic cells, or whether differentiated cells such as granulocytes or erythrocytes of MDS origin also harbor this epigenetic alteration. In this study, we analyzed the methylation status of the p15INK4B gene in MDS by the methylation-specific PCR (MSP) method, which is more sensitive than Southern blotting. The bone marrow mononuclear cells (BM-MNCs) of 23 MDS patients were analyzed, and six of them showed p15INK4B methylation. Progenitor assay with methylcellulose medium was also performed in all patients. In two of the six patients with p15INK4B-methylated BM-MNCs, erythroid and/or non-erythroid colonies formed were subjected to molecular analysis. Colonies with and without p15INK4B methylation were detected in both patients. Furthermore, X-chromosome inactivation (XCI) pattern of each colony was simultaneously determined by MSP-based human androgen receptor gene analysis (HUMARA-MSP), and all p15INK4B-methylated colonies showed the same XCI pattern, which was dominant among the colonies, while p15INK4B-unmethylated colonies showed both patterns of XCI, in each of the two patients. We then examined the methylation status of the p15INK4B gene of granulocyte (PB-PMN) fractions from 10 patients with available peripheral blood cells. In all four patients with p15INK4B-methylated BM-MNCs, their PB-PMNs showed p15INK4B methylation. These results suggest that p15INK4Bmethylation in hematopoietic cells in MDS patients is restricted to the MDS clone but not necessarily to blast cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Russel M, List A, Greenberg P, Woodward S, Glismann B, Parganas E, Ihle J, Taetle R . Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations Blood 1994 84: 1243–1248
Nucifora G, Birn DJ, Espinosa R, Erickson P, LeBeau MM, Roulston D, McKeithan TW, Drabkin H, Rowley JD . Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis Blood 1993 81: 2728–2734
Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD . Consistant intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations Proc Natl Acad Sci USA 1994 91: 4004–4008
Laird PW, Jaenisch R . The role of DNA methylation in cancer genetic and epigenetics Ann Rev Genet 1996 30: 441–464
Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP . Alterations in DNA methylation: a fundamental aspect of neoplasia Adv Cancer Res 1998 72: 141–196
Issa JP, Baylin SB, Herman JG . DNA methylation changes in hematologic malignancies: biologic and clinical implications Leukemia 1997 11: (Suppl. 1) S7–11
Uchida T, Kinoshita T, Nagai H, Nakahara Y, Saito H, Hotta T, Murate T . Hypermethylation of the p15INK4B gene in myelodysplastic syndromes Blood 1997 90: 1403–1409
Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL . A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in indicidual DNA strands Proc Natl Acad Sci USA 1992 89: 1827–1831
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 1996 93: 9821–9826
Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, Baylin SB . Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies Cancer Res 1997 57: 837–841
Quesnel B, Guillerm G, Vereecque R, Wattel E, Preudhomme C, Bauters F, Vanrumbeke M, Fenaux P . Methylation of the p15INK4B gene in myelodysplastic syndrome is frequent and acquired during disease progression Blood 1998 91: 2985–2990
Janssen JW, Buschle M, Layton M, Drexler HG, Lyons J, van den Berghe H, Heimpel H, Kubanek B, Kleihauer E, Muffi GJ, Bartram CR . Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin Blood 1989 73: 248–254
Tsukamoto N, Morita K, Maehara T, Okamoto K, Karasawa M, Omine M, Naruse T . Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphism Br J Haematol 1993 83: 589–594
Ohashi H, Hotta T, Ichikawa A, Kinoshita T, Taguchi R, Kiguchi T, Ikezawa H, Saito H . Peripheral blood cells are predominatly chimeric of affected and normal cells in patients with paroxymal noctural hemoglobinuria (PNH): simultaneous investigation on clonality and expression of glycophosphatidylinositol-anchored proteins Blood 1994 83: 853–859
Maniatis T, Fritsch EF, Sambrook J . Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory, Cold Spring Harbor 1982 pp 9–14
Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW . Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation Am J Hum Genet 1992 51: 1229–1239
Uchida T, Ohashi H, Aoki E, Nakahara Y, Hotta H, Murate T, Saito H, Kinoshita T . Clonality analysis by methylation-specific PCR for the human androgen-receptor gene (HUMARA-MSP) Leukemia (in press)
Suzuki H, Asano H, Ohashi H, Kinoshita T, Murate T, Saito H, Hotta T . Clonality analysis of refractory anemia with ring sideroblasts: simultaneous study of clonality and cytochemistry of bone marrow progenitors Leukemia 1999 13: 130–134
Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF . Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction Proc Natl Acad Sci USA 1991 88: 6846–6852
Asano H, Ohashi H, Ichihara M, Kinoshita T, Murate T, Kobayashi M, Saito H, Hotta T . Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes (MDS) Blood 1994 84: 588–594
Uchida T, Ohashi H, Kinoshita T, Saito H, Taguchi R, Hotta T, Murate T . Hypermethylation of p15INK4B gene in a patient with acute myelogenous leukemia (AML) evoked from paroxymal noctural hemoglobinuria (PNH) Blood 1998 92: 2891–2893
Oscier DG, Worsley A, Darlow S, Figes A, Williams JD, Hamblin TJ . Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score Leukemia Res 1989 13: 833–839
Acknowledgements
We thank Dr Suzuki and Dr Nakahara for suggestions on the experimental procedures, and Ms Hatano and Ms Kondo for technical assistance. This study was supported in part by the Ministry of Health and Welfare's Research Grant for Specific Disease, Japan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aoki, E., Uchida, T., Ohashi, H. et al. Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes. Leukemia 14, 586–593 (2000). https://doi.org/10.1038/sj.leu.2401719
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401719
Keywords
This article is cited by
-
Realgar (α-As4S4) Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation
Chinese Journal of Integrative Medicine (2022)
-
Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine
Annals of Hematology (2013)
-
Tumor-Stammzellforschung – Basis und Herausforderung für Diagnostik und Therapie
Wiener klinische Wochenschrift (2010)
-
A limited number of 5-azacitidine cycles can be effective treatment in MDS
Annals of Hematology (2009)
-
An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients
Annals of Hematology (2005)